wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q55074178-195A45F0-6C2C-4DB8-8680-104590B9D0B6
Q55074178-195A45F0-6C2C-4DB8-8680-104590B9D0B6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55074178-195A45F0-6C2C-4DB8-8680-104590B9D0B6
Emerging Role of Vedolizumab in Managing Refractory Immune Checkpoint Inhibitor-Induced Enteritis.
P2860
Q55074178-195A45F0-6C2C-4DB8-8680-104590B9D0B6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55074178-195A45F0-6C2C-4DB8-8680-104590B9D0B6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
62d066ad5d6f7674f1b36a811f9392d386cfa79d
P2860
The safety of vedolizumab for ulcerative colitis and Crohn's disease.